Archives of Disease in Childhood 儿科· Mudawi, K., Hamud, A., Powell, C., Alnasif, N., Alsaleh, S., Tonbari, A., Salem, R., Zou Zou, A., Alhaji, A., Pullattayil, A. K., Abdelgadir, I. S.·· 2026-10-20精选AI 评分73
在短效β2受体激动剂与全身性糖皮质激素标准一线治疗基础上加用皮下肾上腺素治疗儿童青少年急性严重哮喘发作:随机对照试验系统综述
Use of subcutaneous epinephrine in addition to standard first-line treatment with short-acting {beta}2-agonist and systemic steroids in children and adolescents with an acute severe asthma exacerbation: a systematic review of randomised controlled trials
AI 导读
一项随机对照试验系统综述显示,儿童急性严重哮喘发作时在短效β2受体激动剂和全身性糖皮质激素标准一线治疗基础上加用皮下肾上腺素,未改善哮喘症状或肺功能指标。该综述由世卫组织委托开展,旨在为儿童常见病诊疗建议提供依据,作者认为仍需设计良好的随机对照试验进一步评估其作用。原文见 http://adc.bmj.com/cgi/content/short/111/11/966?rss=1
推荐理由
这篇由世卫组织委托开展的系统综述,汇总了皮下肾上腺素用于儿童急性严重哮喘发作的随机对照试验证据,其结果或为儿童常见病诊疗建议的更新提供依据。
来源:Archives of Disease in Childhood 儿科 · adc.bmj.com